The Centers for Medicare & Medicaid Services Oct. 15 said it will incentivize labs to deliver quicker results to patients undergoing COVID-19 diagnostic testing.

Beginning Jan. 1, 2021, Medicare will pay $100 only to laboratories that complete high throughput COVID-19 diagnostic tests within two calendar days of the specimen’s collection. Also effective Jan. 1, laboratories that take longer than two days to complete these tests will receive a $75 Medicare payment.

“As America continues to grapple with the COVID-19 pandemic, prompt testing turnaround times are more important than ever,” said CMS Administrator Seema Verma, noting that faster high throughput testing will allow patients and physicians to act quickly and decisively with respect to treatment decisions, physical isolation and contact tracing.

Related News Articles

Headline
The Department of Health and Human Services yesterday released initial data on how states and territories plan to use their share of 100 million rapid point-of…
Headline
According to an analysis of COVID-19 hospitalization data from 13 states, released today by the Centers for Disease Control and Prevention, 6% of adults…
Headline
The Food and Drug Administration yesterday approved Veklury (remdesivir) to treat COVID-19 patients age 12 and older who are hospitalized and weigh…
Headline
To continue amplifying the important message of protecting against both the flu and COVID-19, AHA’s United Against the Flu campaign today released new…
Perspective
A COVID-19 vaccine is likely coming soon. Whether it’s next month, at the end of the year or in early 2021, many scientific experts believe we will have one or…
Headline
Three leadership capabilities consistently rise to the top when Andy Shin, chief operating officer for the AHA’s Center for Health Innovation, interviews…